Holy Stone Healthcare Co. Ltd and Cellestis enter into an agreement for the marketing and distribution of QuantiFERON products in Taiwan (July 2002).
Dade Behring SA Pty Ltd and Cellestis enter into an agreement for the marketing and distribution of QuantiFERON products in Southern Africa (July 2002).
- Forums
- ASX - By Stock
- CST
CST
Featured News
Featured News
The Watchlist
P.HOTC
HotCopper
Don Currie, CEO
Don Currie
CEO
Previous Video
Next Video
SPONSORED BY The Market Online